litlas
ログインアカウント作成

Amit Bar‐Or

1992–2025 年に発表

別表記
Amit Bar-Or
242
論文数
43,767
被引用数
110
h 指数
226
i10 指数

被引用数

Amit Bar‐Or の年別被引用数1973 年: 被引用 3 件1993 年: 被引用 1 件1994 年: 被引用 5 件1995 年: 被引用 6 件1996 年: 被引用 6 件1997 年: 被引用 5 件1998 年: 被引用 2 件1999 年: 被引用 3 件2000 年: 被引用 3 件2001 年: 被引用 9 件2002 年: 被引用 18 件2003 年: 被引用 16 件2004 年: 被引用 35 件2005 年: 被引用 65 件2006 年: 被引用 91 件2007 年: 被引用 88 件2008 年: 被引用 159 件2009 年: 被引用 202 件2010 年: 被引用 231 件2011 年: 被引用 264 件2012 年: 被引用 272 件2013 年: 被引用 339 件2014 年: 被引用 370 件2015 年: 被引用 469 件2016 年: 被引用 389 件2017 年: 被引用 457 件2018 年: 被引用 534 件2019 年: 被引用 1,705 件2020 年: 被引用 2,024 件2021 年: 被引用 2,246 件2022 年: 被引用 1,871 件2023 年: 被引用 1,289 件2024 年: 被引用 2,055 件2025 年: 被引用 1,124 件2026 年: 被引用 22 件1974〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,701 件、この内訳の 22.2%ドイツ: 引用元論文 1,346 件、この内訳の 8.1%中国: 引用元論文 1,278 件、この内訳の 7.7%イギリス: 引用元論文 1,150 件、この内訳の 6.9%イタリア: 引用元論文 1,089 件、この内訳の 6.5%カナダ: 引用元論文 935 件、この内訳の 5.6%スイス: 引用元論文 615 件、この内訳の 3.7%フランス: 引用元論文 604 件、この内訳の 3.6%オーストラリア: 引用元論文 486 件、この内訳の 2.9%スペイン: 引用元論文 465 件、この内訳の 2.8%オランダ: 引用元論文 454 件、この内訳の 2.7%日本: 引用元論文 331 件、この内訳の 2%
0%22.2%その他 25.3%

機関

分野

  • Medicine56.8%
  • Biochemistry, Genetics and Molecular Biology14.8%
  • Immunology and Microbiology13.3%
  • Neuroscience12.8%
  • Agricultural and Biological Sciences0.3%
  • Pharmacology, Toxicology and Pharmaceutics0.3%
  • その他1.7%

トピック

  • Multiple Sclerosis Research Studies13.1%
  • Neuroinflammation and Neurodegeneration Mechanisms5.9%
  • Peripheral Neuropathies and Disorders4.7%
  • T-cell and B-cell Immunology3.9%
  • Immunotherapy and Immune Responses2.9%
  • Immune Cell Function and Interaction2.8%
  • その他66.7%

共著者

全論文

検索で開く
  1. Multiple sclerosis

    著者: Massimo Filippi, Amit Bar‐Or, Fredrik Piehl, Paolo Preziosa, Alessandra Solari, Sandra Vukusic, Maria A. Rocca - Nature Reviews Disease Primers 2018 被引用: 1,398

  2. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

    著者: Stephen L. Hauser, Amit Bar‐Or, Gıancarlo Comı, Gavin Giovannoni, Hans‐Peter Hartung, Bernhard Hemmer, Fred Lublin, Xavier Montalbán, Kottil Rammohan, Krzysztof Selmaj, Anthony Traboulsee, Jerry S. Wolinsky, Douglas L. Arnold, Gaëlle Klingelschmitt, Donna Masterman, Paulo Fontoura, Shibeshih Belachew, Peter Chin, Nicole Mairon, Hideki Garren, Ludwig Kappos - New England Journal of Medicine 2016 被引用: 1,961

  3. Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

    著者: Xavier Montalbán, Stephen L. Hauser, Ludwig Kappos, Douglas L. Arnold, Amit Bar‐Or, Giancarlo Comi, de Sèze, Gavin Giovannoni, Hans‐Peter Hartung, Bernhard Hemmer, Fred Lublin, Kottil Rammohan, Krzysztof Selmaj, Anthony Traboulsee, Annette Sauter, Donna Masterman, Paulo Fontoura, Shibeshih Belachew, Hideki Garren, Nicole Mairon, Peter Chin, Jerry S. Wolinsky - New England Journal of Medicine 2016 被引用: 1,856

  4. Ofatumumab versus Teriflunomide in Multiple Sclerosis

    著者: Stephen L. Hauser, Amit Bar‐Or, Jeffrey Cohen, Gıancarlo Comı, Jorge Correale, Patricia K. Coyle, Anne H. Cross, de Sèze, David Leppert, Xavier Montalbán, Krzysztof Selmaj, Heinz Wiendl, Cécile Kerloëguen, Roman Willi, Bingbing Li, Algirdas Kakarieka, Davorka Tomic, Alexandra Goodyear, Ratnakar Pingili, Dieter A. Häring, Krishnan Ramanathan, Martin Merschhemke, Ludwig Kappos - New England Journal of Medicine 2020 被引用: 700

  5. Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course

    著者: Xiaoyuan Zhou, Ryan Baumann, Xiaohui Gao, Myra Mendoza, Sneha Singh, Ilana Katz Sand, Zongqi Xia, Laura M. Cox, Tanuja Chitnis, Hongsup Yoon, Laura Moles, Stacy J. Caillier, Adam Santaniello, Gail Ackermann, Adil Harroud, Robin Lincoln, Refujia Gomez, Antonio González Peña, Elise Digga, Daniel Hakim, Yoshiki Vázquez‐Baeza, Karthik Soman, Shannon Warto, Greg Humphrey, Mauricio Farez, Lisa Ann Gerdes, Jorge R. Oksenberg, Scott S. Zamvil, Siddharthan Chandran, Peter Connick, David Otaegui, Tamara Castillo‐Triviño, Stephen L. Hauser, Jeffrey M. Gelfand, Howard L. Weiner, Reinhard Hohlfeld, Hartmut Wekerle, Jennifer Graves, Amit Bar‐Or, Bruce Cree, Jorge Correale, Rob Knight, Sergio E. Baranzini - Cell 2022 被引用: 319

  6. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

    著者: Ludwig Kappos, Amit Bar‐Or, Bruce Cree, Robert J. Fox, Gavin Giovannoni, Ralf Gold, Patrick Vermersch, Douglas L. Arnold, Sophie Arnould, Tatiana Scherz, Christian Wolf, Erik Wallström, Frank Dahlke, Anat Achiron, Lutz Achtnichts, Kadriye Ağan, Gülşen Akman‐Demir, Alison Allen, Jack P. Antel, Alfredo Rodríguez Antigüedad, Michelle Apperson, Angela Applebee, Guillermo Izquierdo Ayuso, Masayuki Baba, Ovidiu Băjenaru, Rodica Balasa, Belgin Petek Balcı, Michael Barnett, Ann Bass, V. Becker, Mihaela Bejinariu, Florian Then Bergh, Arnfin Bergmann, Evanthia Bernitsas, Achim Berthele, Virender Bhan, Felix Bischof, Randall J. Bjork, Gregg Blevins, Matthias Boehringer, Thomas Boerner, Robert Bonek, James D. Bowen, Allen C. Bowling, Alexey Boyко, Cavit Boz, Vera Bracknies, Stefan Braune, Vincenzo Brescia Morra, Bruno Brochet, Waldemar Brola, Paul Brownstone, M Brozman, Donald Brunet, Ioan Buraga, Margaret Burnett, Mathias Buttmann, Helmut Butzkueven, Jonathan Cahill, Jonathan Calkwood, William Camu, Mark Cascione, G. Castelnovo, Diego Centonze, João Cerqueira, Andrew Chan, Andrea Cimprichová, Stanley Cohan, Giancarlo Comi, Jill Ker Conway, Joanna A. Cooper, John R. Corboy, Jorge Correale, Brian Costell, David A. Cottrell, Patricia K. Coyle, Matthew Craner, Liying Cui, Luı́s Cunha, Anna Członkowska, Ana Silva, Joao de, de Sèze, Marc Debouverie, Jan Debruyne, D. Decoo, G. Defer, Tobias Derfuß, Norma Deri, Bhupesh Dihenia, Péter Diószeghy, Vladimír Donáth, Bénédicte Dubois, Martin Duddy, Pierre Duquette, Gilles Edan, Hüsnü Efendi, Stanton B. Elias, Peter Emrich, Bonaventura Casanova Estruch ほか 228 名 - The Lancet 2018 被引用: 925

  7. B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

    著者: Stephen L. Hauser, Emmanuelle Waubant, Douglas L. Arnold, Timothy R. Vollmer, Jack P. Antel, Robert J. Fox, Amit Bar‐Or, Michael Panzara, Neena Sarkar, Sunil Agarwal, Annette Langer‐Gould, Craig H. Smith - New England Journal of Medicine 2008 被引用: 2,399

  8. Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

    著者: Ralf Gold, Ludwig Kappos, Douglas L. Arnold, Amit Bar‐Or, Gavin Giovannoni, Krzysztof Selmaj, Carlo Tornatore, Marianne T. Sweetser, Minhua Yang, Sarah Sheikh, Katherine Dawson - New England Journal of Medicine 2012 被引用: 1,703

  9. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases

    著者: Ping Shen, Toralf Roch, Vicky Lampropoulou, Richard A. O’Connor, Ulrik Stervbo, Ellen Hilgenberg, Stefanie Ries, Van Duc Dang, Yarúa Jaimes, Capucine Daridon, Rui Li, Luc Jouneau, Pierre Boudinot, Siska Wilantri, Imme Sakwa, Yusei Miyazaki, Melanie D. Leech, Rhoanne C. McPherson, Stefan Wirtz, Markus F. Neurath, Kai Hoehlig, Edgar Meinl, Andreas Grützkau, Joachim R. Grün, Katharina Horn, Anja A. Kühl, Thomas Dörner, Amit Bar‐Or, Stefan H. E. Kaufmann, Stephen M. Anderton, Simon Fillatreau - Nature 2014 被引用: 1,032

  10. Role of B Cells in Multiple Sclerosis and Related Disorders

    著者: Gıancarlo Comı, Amit Bar‐Or, Hans Lassmann, Antonio Uccelli, Hans‐Peter Hartung, Xavier Montalbán, Per Solberg Sørensen, Reinhard Hohlfeld, Stephen L. Hauser - Annals of Neurology 2020 被引用: 278

  11. Bruton tyrosine kinase inhibitors for multiple sclerosis

    著者: Julia Krämer, Amit Bar‐Or, Timothy J. Turner, Heinz Wiendl - Nature Reviews Neurology 2023 被引用: 184

  12. Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial

    著者: Daniel S. Reich, Douglas L. Arnold, Patrick Vermersch, Amit Bar‐Or, Robert J. Fox, André Palma da Cunha Matta, Timothy J. Turner, Erik Wallström, Xinyan Zhang, Miroslav Mareš, Ф. А. Хабиров, Anthony Traboulsee, François Grand’Maison, François Jacques, Anthony Traboulsee, Michaela Týblová, Eva Meluzínová, Radek Ampapa, Martin Vališ, Pavel Hradilke, Miroslav Mareš, Pavel Štourač, Katrin Gross‐Paju, David Laplaud, Guillaume Mathey, Bernard M.J. Uitdehaag, Evgeny Evdoshenkoo, Е. В. Попова, Maria Zakharova, N. А. Totolyan, И. В. Литвиненко, Ф. А. Хабиров, С А Сиверцева, Viera Hančinová, Ema Kantorová, María Luisa Martínez Ginés, Xavier Montalbán, Sara Eichau Maduano, José Meca-Lallana, Lluís Ramió‐Torrentà, Tetyanna Nehrych, V.M. Pashkovskyy, Sergii Moskovko, O. I. Kalbus, Marta Khavunka, Volodymyr Pryshchepa, Alla Goloborodko, Daniel Wynn, William Honeycutt, Sibyl Wray, Brian Steingo, Christopher LaGanke, DeRen Huang, John M. Hemphill, Lawrence Goldstick, Derrick Robertson - The Lancet Neurology 2021 被引用: 192

  13. Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype

    著者: Konrad Gabrusiewicz, Benjamin A.T. Rodriguez, Jun Wei, Yuuri Hashimoto, Luke M. Healy, Sourindra N. Maiti, Ginu Thomas, Shouhao Zhou, Qianghu Wang, Ahmed Elakkad, Brandon Liebelt, Nasser K. Yaghi, Ravesanker Ezhilarasan, Neal Huang, Jeffrey S. Weinberg, Sujit S. Prabhu, Ganesh Rao, Raymond Sawaya, Lauren A. Langford, Janet M. Bruner, Gregory N. Fuller, Amit Bar‐Or, Wei Li, Rivka R. Colen, Michael A. Curran, Krishna Bhat, Jack P. Antel, Laurence J.N. Cooper, Erik P. Sulman, Amy B. Heimberger - JCI Insight 2016 被引用: 454

  14. Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10

    著者: Olga L. Rojas, Anne‐Katrin Pröbstel, Elisa A. Porfilio, A. Wang, Marc Charabati, Tian Sun, Dennis S. W. Lee, Georgina Galicia, Valeria Ramaglia, Lesley A. Ward, Leslie Y. T. Leung, Ghazal Najafi, Khashayar Khaleghi, Beatriz Garcillán, Angela Li, Rickvinder Besla, Ikbel Naouar, Eric Cao, Pailin Chiaranunt, Kyle Burrows, Hannah G Robinson, Jessica R. Allanach, Jennifer Yam, Helen Luck, Daniel Campbell, David Allman, David G. Brooks, Michio Tomura, Ryan Baumann, Scott S. Zamvil, Amit Bar‐Or, Marc S. Horwitz, Daniel A. Winer, Arthur Mortha, Fabienne Mackay, Alexandre Prat, Lisa C. Osborne, Clinton S. Robbins, Sergio E. Baranzini, Jennifer L. Gommerman - Cell 2019 被引用: 388

  15. Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy

    著者: Sokratis A. Apostolidis, Mihir Kakara, Mark M. Painter, Rishi R. Goel, Divij Mathew, Kerry Lenzi, Ayman Rezk, Kristina R. Patterson, Diego A. Espinoza, Jessy C. Kadri, Daniel Markowitz, Clyde Markowitz, Ina Mexhitaj, Dina Jacobs, Allison Babb, Michael R. Betts, Eline T. Luning Prak, Daniela Weiskopf, Alba Grifoni, Kendall A. Lundgreen, Sigrid Gouma, Alessandro Sette, Paul Bates, Scott E. Hensley, Allison R. Greenplate, E. John Wherry, Rui Li, Amit Bar‐Or - Nature Medicine 2021 被引用: 543

  16. Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances

    著者: Amit Bar‐Or, Rui Li - The Lancet Neurology 2021 被引用: 231

  17. Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy

    著者: Rui Li, Ayman Rezk, Yusei Miyazaki, Ellen Hilgenberg, Hanane Touil, Ping Shen, Craig S. Moore, Laure Michel, Faisal Althekair, Sathy Rajasekharan, Jennifer L. Gommerman, Alexandre Prat, Simon Fillatreau, Amit Bar‐Or, on behalf of the Canadian B cells in MS Team - Science Translational Medicine 2015 被引用: 445

  18. Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials

    著者: Amit Bar‐Or, Gian‐Andrea Thanei, Christopher Harp, Corrado Bernasconi, Ulrike Bonati, Anne H. Cross, Saloumeh K Fischer, Laura Gaetano, Stephen L. Hauser, Robert L. Hendricks, Ludwig Kappos, Jens Kühle, David Leppert, Fabian Model, Annette Sauter, Harold Koendgen, Xiaoming Jia, Ann Herman - EBioMedicine 2023 被引用: 88

  19. Reassessing B cell contributions in multiple sclerosis

    著者: Rui Li, Kristina R. Patterson, Amit Bar‐Or - Nature Immunology 2018 被引用: 407

  20. B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies

    著者: Maria Teresa Cencioni, Miriam Mattoscio, Roberta Magliozzi, Amit Bar‐Or, Paolo A. Muraro - Nature Reviews Neurology 2021 被引用: 253

  21. Five years of ocrelizumab in relapsing multiple sclerosis

    著者: Stephen L. Hauser, Ludwig Kappos, Douglas L. Arnold, Amit Bar‐Or, Bruno Brochet, Robert T. Naismith, Anthony Traboulsee, Jerry S. Wolinsky, Shibeshih Belachew, Harold Koendgen, Victoria Levesque, Marianna Manfrini, Fabian Model, Stanislas Hubeaux, Lahar Mehta, Xavier Montalbán - Neurology 2020 被引用: 158

  22. Roles of microglia in brain development, tissue maintenance and repair

    著者: Mackenzie A. Michell‐Robinson, Hanane Touil, Luke M. Healy, David R. Owen, Bryce A. Durafourt, Amit Bar‐Or, Jack P. Antel, Craig S. Moore - Brain 2015 被引用: 406

  23. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells

    著者: Tom A. Barr, Ping Shen, Sheila Brown, Vicky Lampropoulou, Toralf Roch, S. Lawrie, Boli Fan, Richard A. O’Connor, Stephen M. Anderton, Amit Bar‐Or, Simon Fillatreau, David Gray - The Journal of Experimental Medicine 2012 被引用: 643

  24. Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes

    著者: Patrick Waters, Giulia Fadda, Mark Woodhall, Julia O’Mahony, Robert A. Brown, Denise Castro, Giulia Longoni, Sarosh R. Irani, Bo Sun, E. Ann Yeh, Ruth Ann Marrie, Douglas L. Arnold, Brenda Banwell, Amit Bar‐Or, for the Canadian Pediatric Demyelinating Disease Network - JAMA Neurology 2019 被引用: 331